May 10, 2021
Stacey Wahlberg from Cal’s Angels joins us to talk about Cal’s Law out of the Illinois House of Representatives!
House Bill 2109 passed the Illinois House of Representatives, and is now headed to the Senate for consideration. You can follow the status of the legislation by clicking here!
About The Fred Show
Want to know more about The Fred Show? Get their official bio, social pages & articles on 103.5 KISS FM!
Where suburban lawmakers hold sway under the state Capitol dome Lawmakers are racing against a scheduled May 31 adjournment at the Illinois Capitol in Springfield. Associated Press/Seth Perlman Lawmakers are racing against a scheduled May 31 adjournment at the Illinois Capitol in Springfield. Daily Herald file photo
Updated 5/8/2021 5:20 PM
Suburban lawmakers, by their sheer numbers, are on almost every legislative committee in Illinois. But there are some committees, such as appropriations and education in the House and ethics and executive committees in the Senate, where the suburbs have particular sway.
In the House, suburban lawmakers hold 33 seats across five committees relating to appropriations or education.
In Vitro Studies Show Ensovibep (MP0420) Maintains Full Potency Against the Known Mutations of SARS-CoV-2, Including Those Present in Variants First Identified in Brazil, California, India, and New
Share:
In Vitro Studies Show Ensovibep (MP0420) Maintains Full Potency Against the Known Mutations of SARS-CoV-2, Including Those Present in Variants First Identified in Brazil, California, India, and New York, in Addition to the Previously Reported Varia
Ongoing Phase 2 Pilot Study of Ensovibep in Ambulatory Patients Now Expanding Into Second Cohort
Two Global Phase 2 and 3 Clinical Studies of Ensovibep on Track for Initiation This Month
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / May 6, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced results from parallel laboratory studies conducted in collaboration with academic and government partners in Switzerland and the United States. The studies assessed the inhibition of new viral variants by leading SARS-CoV-2 anti-infective molecules, including ensovibep and MP0423. New variants are often associated with fas